The Valley Desk

NCT04589650 · Interventional trial

Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum

Overall registry status Active not recruiting

Phase 2

Conditions PIK3CA-related Overgrowth Spectrum (PROS)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov